TrialCancer2025

Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09).

Miso Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.